» Articles » PMID: 25602997

Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease

Abstract

Importance: The risk of cardiovascular disease (CVD) after infection is poorly understood.

Objective: To determine whether hospitalization for pneumonia is associated with an increased short-term and long-term risk of CVD.

Design, Settings, And Participants: We examined 2 community-based cohorts: the Cardiovascular Health Study (CHS, n = 5888; enrollment age, ≥65 years; enrollment period, 1989-1994) and the Atherosclerosis Risk in Communities study (ARIC, n = 15,792; enrollment age, 45-64 years; enrollment period, 1987-1989). Participants were followed up through December 31, 2010. We matched each participant hospitalized with pneumonia to 2 controls. Pneumonia cases and controls were followed for occurrence of CVD over 10 years after matching. We estimated hazard ratios (HRs) for CVD at different time intervals, adjusting for demographics, CVD risk factors, subclinical CVD, comorbidities, and functional status.

Exposures: Hospitalization for pneumonia.

Main Outcomes And Measures: Incident CVD (myocardial infarction, stroke, and fatal coronary heart disease).

Results: Of 591 pneumonia cases in CHS, 206 had CVD events over 10 years after pneumonia hospitalization. CVD risk after pneumonia was highest in the first year. CVD occurred in 54 cases and 6 controls in the first 30 days (HR, 4.07; 95% CI, 2.86-5.27); 11 cases and 9 controls between 31 and 90 days (HR, 2.94; 95% CI, 2.18-3.70); and 22 cases and 55 controls between 91 days and 1 year (HR, 2.10; 95% CI, 1.59-2.60). Additional CVD risk remained elevated into the tenth year, when 4 cases and 12 controls developed CVD (HR, 1.86; 95% CI, 1.18-2.55). In ARIC, of 680 pneumonia cases, 112 had CVD over 10 years after hospitalization. CVD occurred in 4 cases and 3 controls in the first 30 days (HR, 2.38; 95% CI, 1.12-3.63); 4 cases and 0 controls between 31 and 90 days (HR, 2.40; 95% CI, 1.23-3.47); 11 cases and 8 controls between 91 days and 1 year (HR, 2.19; 95% CI, 1.20-3.19); and 8 cases and 7 controls during the second year (HR, 1.88; 95% CI, 1.10-2.66). After the second year, the HRs were no longer statistically significant.

Conclusions And Relevance: Hospitalization for pneumonia was associated with increased short-term and long-term risk of CVD, suggesting that pneumonia may be a risk factor for CVD.

Citing Articles

Unlike common pneumonia, COVID-19 is a risk factor for multiple cardiovascular diseases: A two-sample Mendelian randomization study.

Li C, Chen H Medicine (Baltimore). 2025; 103(52):e41015.

PMID: 39969327 PMC: 11688020. DOI: 10.1097/MD.0000000000041015.


[Real world data show effectiveness of new respiratory syncytial virus (RSV) vaccines].

Matt U, Nitschmann S, Herold S Inn Med (Heidelb). 2025; .

PMID: 39945806 DOI: 10.1007/s00108-025-01852-1.


The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients.

Jankowiak B, Wleklik M, Rosiek-Biegus M Vaccines (Basel). 2025; 12(12.

PMID: 39771983 PMC: 11679989. DOI: 10.3390/vaccines12121321.


Respiratory Pathology and Cardiovascular Diseases: A Scoping Review.

Campos-Rodriguez F, Chiner E, de la Rosa-Carrillo D, Garcia-Cosio B, Hernadez-Hernandez J, Jimenez D Open Respir Arch. 2025; 7(1):100392.

PMID: 39758960 PMC: 11696865. DOI: 10.1016/j.opresp.2024.100392.


The Peril that Lies in Wait for Patients Admitted with Chronic Obstructive Pulmonary Disease Exacerbation.

Aaron S Ann Am Thorac Soc. 2024; 21(11):1485-1486.

PMID: 39485170 PMC: 11568498. DOI: 10.1513/AnnalsATS.202408-810ED.


References
1.
Town M, Naimi T, Mokdad A, Brewer R . Health care access among U.S. adults who drink alcohol excessively: missed opportunities for prevention. Prev Chronic Dis. 2006; 3(2):A53. PMC: 1563973. View

2.
Yende S, Alvarez K, Loehr L, Folsom A, Newman A, Weissfeld L . Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts. Chest. 2013; 144(3):1008-1017. PMC: 3760741. DOI: 10.1378/chest.12-2818. View

3.
Maclure M, Mittleman M . Should we use a case-crossover design?. Annu Rev Public Health. 2000; 21:193-221. DOI: 10.1146/annurev.publhealth.21.1.193. View

4.
Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S . Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003; 107(5):762-8. DOI: 10.1161/01.cir.0000048190.68071.2b. View

5.
Foley R, Guo H, Snyder J, Gilbertson D, Collins A . Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol. 2004; 15(4):1038-45. DOI: 10.1097/01.asn.0000119144.95922.c4. View